Companies: 10,795·Total market cap: $144.5T
FusionPharm, Inc.

FusionPharm, Inc.

FSPMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1259
P/E Ratio
52W High$0.0001
52W Low$0.0001
Overview

FusionPharm, Inc. (FSPM) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · FSPM · as of Jun 8, 2026

Key Statistics

EPS (TTM)fspm eps ttm · fspm earnings per shareEarnings history
PE Ratio (TTM)fspm pe ratio ttm · fspm price to earningsPE Ratio deep dive
Revenue (TTM)fspm revenue ttm · fspm annual revenueFull revenue history
Dividend YieldNo Dividenddoes fspm pay dividends · fspm dividend yieldDividend history
Shares Outstandingfspm shares outstanding · fspm floatShares outstanding history
Next EarningsTBAfspm earnings date · fspm next earningsEarnings history

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+0.00%

About FusionPharm, Inc.

CEOWilliam J. Sears
IPO DateMay 12, 1993
Employees4
CountryUS

FusionPharm, Inc. specializes in the development, manufacturing, and sale of advanced indoor cultivation systems, marketed under its PharmPod brand. These enclosed growing units are distributed across…

what is fusionpharm, inc. · fspm stock overview · fusionpharm, inc. company profile · who is fusionpharm, inc. ceo · fspm OTC · fusionpharm, inc. headquarters · fusionpharm, inc. business segments

About Stock Overview & Key Data

FusionPharm, Inc. (FSPM) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on OTC since May 12, 1993. As of the latest trading session, FSPM stock price is $0.00, with a market capitalization of $1,259. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

Frequently Asked Questions

As of the latest trading session, FusionPharm, Inc. (FSPM) stock price is $0.00. The stock is traded on OTC under the ticker symbol FSPM. The 52-week range is $0.00 – $0.00.

FSPM stock priceFSPM quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice